Certara introduces Libra™, an AI-powered tool within ToxStudio® to predict drug-induced liver injury (DILI) early in discovery. Using QSAR modeling, Bayesian analytics, and automated reporting, Libra helps researchers improve drug safety, reduce late-stage failures, and align with FDA’s 2025 roadmap on New Approach Methodologies.
